The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...

We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Pakistan Prime Minister Muhammad Shehbaz Sharif (left) meets Chief Advisor of the Interim Government of Bangladesh Dr. Muhammad Yunus on the sidelines of the United ...

Despite a market bloodbath that left the S&P 500 down 4.84%, Vertex Pharmaceuticals managed a modest gain of 0.11%, flaunting resilience. The biotech firm outpaced the broader medical sector over the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Find out what's up in your night sky during April 2025 and how to see it in this Space.com stargazing guide. Looking for a telescope for the next night sky event? We recommend the Celestron ...

The AICPA endorsed four of the six bills, all of which passed with bipartisan support and were forwarded to the Senate.